The food-processing sector constitutes up to 10% of the GDP within India’s Agriculture and Manufacturing sector. Agriculture employs about 60% of the population and contributes 14% to the GDP. In fiscal 2012, India produced 127.3 million t of milk, representing 17% of the global market. The country produced 7.0 million t of pulses, 155.7 million […]
R&D spending by Germany’s chemical industry was a record high of €10.5 billion ($14.1 billion) in 2013, up 8.2%. The number of personnel researching new products or processes grew by just under 5% to 44,500, while the growth of staff in the overall sector increased by 1.3%. The chemical sector had the third-largest research budget […]
An August report by Cochilco, Chile’s copper commission, states that the country’s mining investment is expected to be $105 billion between 2014 and 2023, a decrease of 7.5% from last year’s estimate. Projects in the copper industry will receive $81 billion, while $23 billion will be for projects in gold, silver, iron ore and other […]
R&D spending by 264 Japanese companies will increase 4% this fiscal year to JPY 11.6 trillion ($112 billion), compared to a 5.4% increase in fiscal 2014, according to a survey by Nikkei. About 20% of those firms will be building or expanding their R&D facilities overseas. The companies investing the most in R&D are Toyota […]
The growth in steelmaking capacity in countries outside the Organization for Economic Co-operation and Development (OECD) is slowing. In 2014, such capacity is expected to reach 1.56 billion tons per year (tpy), a 5.5% increase in average annual capacity since 2011 or a 17.4% increase in total. Asia is estimated to account for 81% of […]
The US Congress may permanently place some synthetic drugs on Schedule I of the Controlled Substances Act (CSA). They include cannabinoids and stimulants such as methamphetamine, MDMA and “bath salts.” Complicating considerations are designer drugs, or synthetics with their structures altered to have the same effect as yet not be chemically similar to controlled substances—a […]
Of over 3,400 food-safety violations in 2013 connected to exported raw or minimally processed products from 117 countries, the three most common categories of food violating the inspecting countries’ regulations were seafood, vegetables and fruits, accounting for 24%, 20% and 14% of incidents, respectively. The top three countries of origin of the foods associated with […]
Washington, DC 8/29/14—Bio-Rad Laboratories stated in an SEC filing that Bradford J. Crutchfield, executive vice president and president of its Life Sciences Group, is no longer employed by the company, effective August 26. A replacement has yet to be named.
Montpellier, France 8/11/14 ; Paris, France 8/12/14—Alpha MOS, which filed for bankruptcy last year (see IBO 12/15/13), has announced that publicly held French company DMS, a provider of diagnostic medical-imaging systems, plans to make an investment in the company as part of a capital increase that will also include current shareholders. The offering will take […]
Paris, France 7/21/14; St. Ives, UK 7/22/14 —Environnement, a publicly held French provider of online environmental monitors, has acquired UK-based PCME for €8 million ($11 million = €0.74 = $1). PCME supplies continuous particulate monitors for industrial processes and had fiscal 2014 revenues of €10 million ($14 million). “The expertise of PCME for the monitoring […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
